Genetic Engineering

Elena Veduta is the Head of the Department of Strategic Planning and Economic Policy of Lomonosov Moscow State University Capitalism is a chaotically organized economy,...

By Sarah Lawton Nov. 23, 2020 Following their three-day virtual party conference, Germany’s Greens have a new basic programme, including a commitment to the Paris Climate...

18 May 2020 Moderna’s chief medical officer has described the company’s products as “hacking the software of life” and permanently altering a person’s genetic code....

December 18, 2017 Pesticide suicide refers to toxic chemicals mucking up the health of animals, plants and insects. This worldwide causatum may be totally out...

In September 2016 it was announced that German chemical & pharmaceutical giant Bayer agreed to buy US seeds and pesticides corporation Monsanto in a $66 billion takeover deal. If the sides finalize the agreement (which is to be signed by the end of 2017) and regulatory authorities in USA and EU approve it, it will create a «transatlantic monster», the likes of which the world has never seen before. The new company will to a great extent dictate to the whole world what to eat, what medicine to take and how to run agriculture.

Last week the U.S. corporation Monsanto, which holds a leading position in the global market of genetically modified organisms (GMOs), reached a licensing agreement with the Broad Institute, Cambridge, USA, on the commercial use of the innovative genome-editing technology CRISPR/Cas9 for agriculture applications. This news has led some experts to